Anticancer Drug Therapy in the Older Cancer Patient: Pharmacology and Polypharmacy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-008-0060-6.pdf
Reference61 articles.
1. Venook AP, Egorin MJ, Rosner GL, et al.: Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565. J Clin Oncol 2000, 18:2780–2787
2. Venook AP, Enders Klein C, Fleming G, et al.: A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863. Ann Oncol 2003;14:1783–1790, doi: 10.1093/annonc/mdg493
3. Smith TJ, Khatcheressian J, Lyman GH, et al.: 2006 Update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 2006;24:3187–3205
4. Launay-Vacher V, Oudard S, Janus N, et al.: Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer 2007;110:1376–1384, doi: 10.1002/cncr.22904
5. Lichtman SM, Wildiers H, Launay-Vacher V, et al.: International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer 2007;43:14–34
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rethinking toxicity testing: Influence of aging on the outcome of long-term toxicity testing and possible remediation;Food and Chemical Toxicology;2020-07
2. Pharmacology of Aging and Cancer;Geriatric Oncology;2020
3. Comprehensive Geriatric Assessment (CGA) for Cancer Patients;Geriatric Oncology;2020
4. Predictors of adverse drug reactions in geriatric patients: An exploratory study among cancer patients;South Asian Journal of Cancer;2019-04
5. Comprehensive Geriatric Assessment (CGA) for Cancer Patients;Geriatric Oncology;2018-11-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3